Since IFNγ given 48 hours following infection did not protect IFNAR-/- mice against EBOV GP/rVSV (Fig 5A), in these studies we assessed the protection IFNγ conferred against MA-EBOV when administered 24 hours prior to, at the time of infection, 6 or 24 hours following infection. Here, IFNAR1 is linked to infection.